As part of our new special feature, we’ve pulled together a selection of the top resources and technologies to advance your infectious disease research and virology understanding.
Read on to explore the recent learnings in COVID-19 research and the latest developments in viral therapeutics, from Ebola vaccines to next-generation antifungals. Plus, find out more about new technologies designed to help you master cell seeding and enabling viral gene expression analysis in real time.
In this article, we speak with Kevin Entzminger, Director of Antibody Discovery and Engineering at Abwiz Bio, to learn more about how virus-neutralizing antibodies have proven to be a key tool in the fight against SARS-CoV-2, the advantages of using Octet in this work, and why science communication and collaboration between researchers is so important.
In this video, Dr. Rebecca Dubois, University of California, outlines the advantages of using Sartorius' Octet® platform in her research to understand the molecular mechanisms of human viral infection and to develop new vaccines and antiviral therapies.
In this application note, find out how protein detection and quantification can be streamlined for vaccine development, for Ebola and other diseases, with Simple Western instrumentation.
In this application note, Sartorius presents a series of four articles, demonstrating the immune response to SARS-CoV-2 at a molecular level and its importance to the development of effective vaccines, treatments, and prognostic tests.
In this article, PromoCell explores the potential of HLA-type to be used to identify individuals at greater risk from SARS-CoV-2 infection, explain differences in the epidemic trend in different countries, and also help in the development of novel vaccines.
In this application note, BMG LABTECH describes a method to analyze viral gene expression in near real time using fluorescence as a proxy for infection.
In this application note, INTEGRA Biosciences demonstrates how cell viability, avoidance of contamination, high experimental reproducibility, and accuracy can be mastered by utilizing the VIAFLO 96 and VIAFLO 384 handheld electronic pipettes.
Take a look at what other researchers and clinicians all over the world are saying about the latest equipment and technologies driving infectious disease research. Here, Natalia Pascale, Biopas, shares her opinion on the iQue®3 by Sartorius Group.
Find more news and resources in our Virology & Infectious Disease Special Feature >>